CAS: 879507-25-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | NRC-AN-019 REF: 3D-EKB50725CAS: 879507-25-2 | Min. 95% | To inquire | Mon 26 Aug 24 |
 | AN-019 REF: TM-T26625CAS: 879507-25-2 | 98.01% | 274.00 €~2,336.00 € | Tue 03 Sep 24 |
NRC-AN-019
CAS:879507-25-2
NRC-AN-019 is an imatinib-resistant drug that belongs to the class of bcr-abl inhibitors. It has …
Formula:
C25H17F6N5O
Purity:
Min. 95%
Molecular weight:
517.4 g/mol
Ref: 3D-EKB50725
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 26 Aug 2024
AN-019
CAS:879507-25-2
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic …
Formula:
C25H17F6N5O
Purity:
98.01%
Color and Shape:
Solid
Molecular weight:
517.43
Ref: TM-T26625
| 1mg | 274.00 € | ||
| 5mg | 675.00 € | ||
| 10mg | 923.00 € | ||
| 25mg | 1,421.00 € | ||
| 50mg | 1,850.00 € | ||
| 100mg | 2,336.00 € |
Estimated delivery in United States, on Tuesday 3 Sep 2024
